GYPC and infection: ,55,75,76 After natural infection in humans, low levels of neutralising antibodies have been reported during convalescence58,77 and vaccination of a non-human primate model with a DNA-based CCHFV vaccine, containing plasmids encoding the GPC and NP, provided protection against CCHF and induced high antibody titres but with no neutralising activity.35